Evolving frontline immunochemotherapy for mantle cell lymphoma and the impact on survival outcomes

Because there have been a dvances in frontline treatment for mantle cell lymphoma (MCL) over the last 2 decades, we sought to characterize the changes in frontline treatment patterns and their association with outcomes. Patients with newly diagnosed MCL from September 2002 through June 2015 were enr...

Descripción completa

Detalles Bibliográficos
Autores principales: Castellino, Alessia, Wang, Yucai, Larson, Melissa C., Maurer, Matthew J., Link, Brian K., Farooq, Umar, Feldman, Andrew L., Syrbu, Sergei I., Habermann, Thomas M., Paludo, Jonas, Inwards, David J., Witzig, Thomas E., Ansell, Stephen M., Allmer, Cristine, Slager, Susan L., Cohen, Jonathon B., Martin, Peter, Cerhan, James R., Nowakowski, Grzegorz S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2022
Materias:
Lymphoid Neoplasia
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8864651/
https://www.ncbi.nlm.nih.gov/pubmed/34662895
http://dx.doi.org/10.1182/bloodadvances.2021005715

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8864651/
https://www.ncbi.nlm.nih.gov/pubmed/34662895
http://dx.doi.org/10.1182/bloodadvances.2021005715

Ejemplares similares